Since the time of Pasteur, rabies. vaccine has long been used as a prophylactic as therapeutic measure for both human and animal. Use of small experimental animal, especially mice, for the quantitative determination of its immunogenicity, however, was not in practice before the year 1930. Following the introduction of Habel's test, it has become a general practice to employ this test for the assay of the immunogenicity of rabies vaccine. In Japan too, this test is used for the assay of both human and animal vaccine.
In order to eliminate the fault of Habel's test which shows a socalled paradoxical phenomenon (lower fatality of the mice receiving larger challenge dose), attempts were made to improve the method of immunization and challenge. A study was also made on the possibility of expressing the immunizing effect of vaccine by the amount of effective tissue inoculated. Stated in the following are the results of such studies made on different vaccines prepared by the author himself.
1. When DD stock mice are used, those immunized with the vaccine of the dilutions within a certain limit show the results from total death to total survival by the change of the challenge dose, namely, it was found that within a certain limit the immunizing dose, there exists a correlation between immunizing dose and of challenge dose.
2. Various kinds of rabies vaccines, some of which were actually in use and some under test production, were prepared and their immunogenicity was compared, in the term of the amount of the effective immunogenic tissue contained, employing varying dilutions of the vaccine and a constant dose of challenge. The results showed that all the brain tissue vaccines prepared in the present study were similar in their immunogenicity, the inoculation of vaccine in a concentration of around 0.1% protecting the mice against the intracerebral challenge of 5-20 LD
50. Vaccines prepared by the use of the spinal cord, however, showed poor immunogenicity.
3. The vaccines prepared in the present study showed virtually no deterioration in their immunogenicity by the storage in a cold chamber (0-4°C) for 6 months. Freeze-drying gave no change in the immunogenicity of the vaccine inactivated by the irradiation of ultraviolet ray.
4. Inoculation of the vaccine equivalent to 0.1% brain tissue dilution in a dose of 0.5 ml repeated for 2 times could protect the immunized mice against the challenge the fixed virus which caused the death of nearly all the mice of the control group with the level of significance X
2<0.01 and, moreover, it could protect the animal completely against the intramuscular challenge of the street virus.
View full abstract